T. Rowe Price Associates’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$124M Sell
3,126,073
-138,961
-4% -$5.49M 0.01% 528
2025
Q1
$98.5M Sell
3,265,034
-561,905
-15% -$17M 0.01% 554
2024
Q4
$134M Sell
3,826,939
-383,233
-9% -$13.4M 0.02% 507
2024
Q3
$169M Buy
4,210,172
+275,861
+7% +$11.1M 0.02% 464
2024
Q2
$188M Buy
3,934,311
+412,108
+12% +$19.6M 0.02% 431
2024
Q1
$153M Sell
3,522,203
-732,871
-17% -$31.8M 0.02% 470
2023
Q4
$215M Buy
4,255,074
+497,077
+13% +$25.1M 0.03% 407
2023
Q3
$170M Sell
3,757,997
-77,870
-2% -$3.53M 0.03% 419
2023
Q2
$157M Sell
3,835,867
-99,084
-3% -$4.07M 0.02% 434
2023
Q1
$141M Sell
3,934,951
-357,480
-8% -$12.8M 0.02% 453
2022
Q4
$162M Sell
4,292,431
-504,701
-11% -$19.1M 0.03% 411
2022
Q3
$212M Sell
4,797,132
-10,258,914
-68% -$454M 0.03% 348
2022
Q2
$557M Buy
15,056,046
+705,586
+5% +$26.1M 0.07% 269
2022
Q1
$532M Buy
14,350,460
+1,860,180
+15% +$68.9M 0.05% 318
2021
Q4
$380M Buy
12,490,280
+752,959
+6% +$22.9M 0.03% 400
2021
Q3
$394M Sell
11,737,321
-521,506
-4% -$17.5M 0.04% 389
2021
Q2
$489M Sell
12,258,827
-321,229
-3% -$12.8M 0.05% 341
2021
Q1
$566M Sell
12,580,056
-534,911
-4% -$24M 0.06% 308
2020
Q4
$742M Buy
13,114,967
+2,382,942
+22% +$135M 0.08% 264
2020
Q3
$509M Buy
10,732,025
+2,120,663
+25% +$101M 0.06% 300
2020
Q2
$508M Buy
8,611,362
+4,848,917
+129% +$286M 0.06% 295
2020
Q1
$178M Buy
3,762,445
+1,898,009
+102% +$89.7M 0.03% 439
2019
Q4
$113M Sell
1,864,436
-85,428
-4% -$5.16M 0.01% 631
2019
Q3
$117M Sell
1,949,864
-35,503
-2% -$2.13M 0.02% 583
2019
Q2
$128M Sell
1,985,367
-482,102
-20% -$31M 0.02% 586
2019
Q1
$200M Buy
2,467,469
+1,318,345
+115% +$107M 0.03% 469
2018
Q4
$62.1M Buy
1,149,124
+54,588
+5% +$2.95M 0.01% 742
2018
Q3
$56.5M Sell
1,094,536
-107,097
-9% -$5.52M 0.01% 872
2018
Q2
$50.1M Sell
1,201,633
-140,299
-10% -$5.85M 0.01% 898
2018
Q1
$59.2M Sell
1,341,932
-46,646
-3% -$2.06M 0.01% 813
2017
Q4
$69.8M Buy
1,388,578
+264,678
+24% +$13.3M 0.01% 748
2017
Q3
$57M Sell
1,123,900
-13,321
-1% -$675K 0.01% 796
2017
Q2
$57.9M Sell
1,137,221
-736,738
-39% -$37.5M 0.01% 777
2017
Q1
$75.3M Sell
1,873,959
-26,646
-1% -$1.07M 0.01% 674
2016
Q4
$90.9M Buy
1,900,605
+867,505
+84% +$41.5M 0.02% 627
2016
Q3
$37.9M Sell
1,033,100
-307,538
-23% -$11.3M 0.01% 905
2016
Q2
$31.2M Buy
1,340,638
+26,410
+2% +$615K 0.01% 945
2016
Q1
$53.2M Sell
1,314,228
-86,259
-6% -$3.49M 0.01% 750
2015
Q4
$86.7M Sell
1,400,487
-277,056
-17% -$17.2M 0.02% 593
2015
Q3
$67.8M Buy
1,677,543
+27,738
+2% +$1.12M 0.02% 686
2015
Q2
$94.9M Buy
1,649,805
+160,547
+11% +$9.24M 0.02% 613
2015
Q1
$94.8M Sell
1,489,258
-1,189,120
-44% -$75.7M 0.02% 637
2014
Q4
$165M Sell
2,678,378
-76,372
-3% -$4.72M 0.04% 481
2014
Q3
$107M Sell
2,754,750
-11,528
-0.4% -$448K 0.02% 592
2014
Q2
$95.3M Sell
2,766,278
-462,979
-14% -$15.9M 0.02% 648
2014
Q1
$140M Sell
3,229,257
-120,158
-4% -$5.19M 0.03% 528
2013
Q4
$133M Sell
3,349,415
-63,630
-2% -$2.54M 0.03% 532
2013
Q3
$128M Sell
3,413,045
-422,710
-11% -$15.9M 0.03% 523
2013
Q2
$103M Buy
+3,835,755
New +$103M 0.03% 563